Trevi Therapeutics reports Q1 EPS (11c), consensus (9c)
PremiumThe FlyTrevi Therapeutics reports Q1 EPS (11c), consensus (9c)
3M ago
Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
PremiumPress Releases
Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
3M ago
Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates
PremiumPress Releases
Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates
4M ago
Trevi Therapeutics reports Q3 EPS (8c), consensus (9c)
PremiumThe FlyTrevi Therapeutics reports Q3 EPS (8c), consensus (9c)
9M ago
Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business Update
9M ago
Trevi Therapeutics initiates Phase 2a RIVER clinical trial of Haduvio
PremiumThe Fly
Trevi Therapeutics initiates Phase 2a RIVER clinical trial of Haduvio
9M ago
Trevi Therapeutics files $200M mixed securities shelf
PremiumThe FlyTrevi Therapeutics files $200M mixed securities shelf
1y ago
Trevi Therapeutics Announces First Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
Trevi Therapeutics Announces First Quarter 2023 Financial Results and Provides Business Update
1y ago
TRVI Earnings this Week: How Will it Perform?
PremiumPre-Earnings
TRVI Earnings this Week: How Will it Perform?
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100